
Loading, please wait...

Loading, please wait...

Researchers examined 577 young women and found that contraceptive users had higher pulse-wave velocity (PWV), indicating increased arterial stiffness, compared to non-users. Menstrual phase and contraceptive type (oral vs. parenteral) did not affect PWV. Other arterial measures (AIx, cIMT) showed no significant differences. Biomarkers only partially explained the PWV difference. Contraceptives independently impact arterial stiffness.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers examined 577 young women and found that contraceptive users had higher pulse-wave velocity (PWV), indicating increased arterial stiffness, compared to non-users. Menstrual phase and contraceptive type (oral vs. parenteral) did not affect PWV. Other arterial measures (AIx, cIMT) showed no significant differences. Biomarkers only partially explained the PWV difference. Contraceptives independently impact arterial stiffness.
2 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday